Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing insulin lispro and insulin lispro protamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic lispro 25/75 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic lispro 50/50 100u/mL injection solution 3mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin biphasic lispro 25/75 100units/mL injection 3mL cartridge(product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro biphasic (recombinant human insulin analogue) 50/50 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 10ml vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 1.5ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml injection 3ml cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro biphasic (recombinant human insulin analogue) 25/75 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro (recombinant human insulin analogue) 100units/ml injection 3ml pre-filled disposable injection device |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro 100iu/mL injection vial (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro 100units/mL injection 3mL cartridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
insuline lispro 100 unités/mL, stylo prérempli de 3 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro 100units/mL injection 1.5mL cartridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing insulin lispro biphasic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro protamine |
Is a |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Insulin lispro-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lispro insulin 150 unit/1.5 milliliter conventional release solution for injection cartridge |
Has precise active ingredient |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lispro insulin 150 unit/1.5 milliliter conventional release solution for injection cartridge |
Has basis of strength substance (attribute) |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lispro insulin 1000 unit/10 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lispro insulin 1000 unit/10 milliliter conventional release solution for injection vial |
Has precise active ingredient |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lispro insulin 300 unit/3 milliliter conventional release solution for injection cartridge |
Has basis of strength substance (attribute) |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lispro insulin 300 unit/3 milliliter conventional release solution for injection cartridge |
Has precise active ingredient |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lispro insulin 300 unit/3 milliliter conventional release solution for injection syringe |
Has basis of strength substance (attribute) |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lispro insulin 300 unit/3 milliliter conventional release solution for injection syringe |
Has precise active ingredient |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin lispro only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin lispro only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely insulin lispro 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely insulin lispro 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin lispro protamine |
Is modification of (attribute) |
False |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing insulin lispro and insulin lispro protamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only insulin lispro and insulin lispro protamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin lispro protamine- and insulin lispro-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin lispro and insulin lispro protamine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin lispro 200 unit/mL solution for injection |
Has precise active ingredient |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Insulin lispro 200 unit/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Insulin lispro |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |